Etaracizumab
Humanized (from mouse) | |
|---|---|
| Target | alpha-v beta-3 integrin |
| Clinical data | |
| Trade names | Abegrin |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6392H9908N1732O1996S42 |
| Molar mass | 144302.22 g·mol−1 |
  (what is this?) (verify) | |
Etaracizumab, also known as MEDI-522, trade name Abegrin, is a
metastatic melanoma, prostate cancer,[1] ovarian cancer[2] and various other types of cancer.[3] It is manufactured by MedImmune.[1]
It is an enhanced iteration of Vitaxin, also known as MEDI-523. Both are derived from the mouse antibody LM609.[4]
References
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |